Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

NCT00111618 is registered in ClinicalTrials.gov with Antisoma Research as lead sponsor.

NCT NCT00111618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Lead sponsor
Antisoma Research
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
August 31, 2008
Enrollment
70 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer